- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Oct 30, 2024 | 44.83M sh |
| Short Term Debt | Q3 2024 · Sep 30, 2024 | $50M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $72.69M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $142.09M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $377.41M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $404.23M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $201.31M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $165.11M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $260.35M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $286.5M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $258.84M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $316.92M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $616.17M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $673.64M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $50M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 43.32M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 42.77M sh |
| Capex restated | Q3 2024 · Sep 30, 2023 | $4.72M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$20.6M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.96 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$2.61 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.96 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$2.61 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $59.62M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $173.89M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $56.44M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $166.99M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$41.43M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$111.82M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$31.05M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$99.83M |
| Revenue | Q3 2024 · Sep 30, 2023 | $130.39M |
| Revenue | Q3 2024 · Sep 30, 2023 | $384.1M |